By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina said today that The Broad Institute has joined the Illumina Genome Network.

The Broad Institute will offer its proprietary sample preparation processes for sequencing of "challenging low-input DNA" and formalin-fixed, paraffin-embedded samples, said Illumina. Projects for the specialized service will be jointly evaluated by The Broad Institute and Illumina.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.